Table 3.
Barriers to ADRs reporting
| Strongly agree (%) | Agree (%) | Neutral (%) | Disagree (%) | Strongly disagree (%) | Relative index | Rank | p Value | |
|---|---|---|---|---|---|---|---|---|
| Reporting forms are not available | 200 (98.5) | 2 (1.0) | 1 (0.5) | 0 | 0 | 0.996 | 2 | 0.554 |
| Reporting may be time consuming | 0 | 74 (36.5) | 89 (43.8) | 40 (19.7) | 0 | 0.633 | 8 | 0.0112 |
| I fear legal liability for the reported ADR | 78 (38.4) | 66 (32.5) | 46 (22.7) | 13 (6.4) | 0 | 0.806 | 6 | 0.045* |
| I am not motivated to report | 188 (92.6) | 7 (3.4) | 8 (3.9) | 0 | 0 | 0.977 | 3 | 0.080 |
| I do not know how to report | 201 (99.0) | 2 (1.0) | 0 | 0 | 0 | 0.998 | 1 | 0.789 |
| I am not confident whether it is an ADR or not | 141 (69.5) | 34 (16.7) | 7 (3.4) | 19 (9.4) | 2 (1.0) | 0.889 | 5 | 0.046* |
| Insufficient knowledge of pharmacotherapy in detecting ADR | 71 (35.0) | 58 (28.6) | 11 (5.4) | 59 (29.1) | 4 (2.0) | 0.731 | 7 | 0.018* |
| Lack of professional setup/body to discuss about ADR | 157 (77.3) | 37 (18.2) | 2 (1.0) | 7 (3.4) | 0 | 0.939 | 4 | 0.040* |
*, Significant, fisher exact test was applied, education level was used as grouping variable.
ADRs, adverse drug reactions.